文献速递糖尿病

2型糖尿病视网膜神经功能障碍与认知障碍的关系:RECOGNISED横断面研究

Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study.
PubMed 文献 · Diabetologia · 2026-01-29

该研究分析RECOGNISED项目313例2型糖尿病患者的基线数据,其中185例轻度认知障碍(MCI)、128例认知正常。研究发现MCI患者视网膜敏感性和注视固定能力更差,瞳孔面积比和明适应b波振幅存在显著组间差异;结合视网膜指标、教育年限、DSDRS和MoCA的模型识别MCI的AUC为0.84(敏感性79.9,特异性79.0)。

要点

  • MCI患者视网膜敏感性更低、注视固定能力更差,瞳孔面积比和明适应b波振幅有差异。
  • 联合视网膜神经功能指标与简单临床变量的模型识别MCI的AUC达0.84。
  • 视空间建构域受损与视网膜敏感性和注视固定独立相关。

核心结论

  • 评估视网膜神经功能障碍结合简单临床变量有助于识别2型糖尿病合并MCI的患者。

研究设计与样本

  • RECOGNISED项目(Horizon 2020资助的欧洲项目)的横断面基线数据分析,共纳入313例2型糖尿病患者。
  • 纳入标准包括年龄≥65岁、2型糖尿病病程超过5年、无卒中或神经退行性疾病史、无或仅轻中度非增殖性糖尿病视网膜病变。
  • MCI与认知正常基于完整神经心理测试组合和临床痴呆评定量表确定。

主要发现

  • MCI患者较认知正常者年龄更大(p=0.006)、受教育年限更少(p<0.001)、视网膜敏感性更低(p=0.01)、注视固定能力更差(p≤0.001)。
  • 瞳孔面积比(p=0.002)和明适应b波振幅(p=0.03)在MCI与认知正常组间差异有统计学意义。
  • 最佳多变量logistic回归模型结合视网膜敏感性、注视固定、明适应b波振幅、刺激后瞳孔大小变化、受教育年限、DSDRS和MoCA评分,AUC为0.84(敏感性79.9,特异性79.0)。
  • 视空间建构域在MCI患者中受损最严重,其损害与视网膜敏感性和注视固定独立相关。

关键数值与推荐

  • MCI诊断基于完整神经心理测试组合和临床痴呆评定量表评分。
  • 最佳预测模型AUC为0.84,敏感性79.9,特异性79.0。

临床怎么用

  • 可考虑将视网膜神经功能评估(如微视野检查、便携式视网膜电图)与简单临床变量结合,用于2型糖尿病患者的MCI筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: There are no robust, reliable and easy to administer tests to screen for mild cognitive impairment (MCI) in people living with diabetes. Since the retina is ontogenically brain-derived, we hypothesised that retinal biomarkers could be used, alone or in combination with other simple tests, to screen for MCI in people with diabetes. METHODS: Baseline data from participants screened for RECOGNISED, a Horizon 2020-funded European project, were analysed. Main eligibility criteria for RECOGNISED included age ≥65 years, type 2 diabetes of over 5 years standing, no previous history of stroke or neurodegenerative disease, and no overt diabetic retinopathy or only mild-to-moderate non-proliferative diabetic retinopathy. Baseline characteristics of participants, including scores from the Montreal Cognitive Assessment test (MoCA) and Self-Administered Gerocognitive Examination, the Diabetes Specific Dementia Risk Score (DSDRS) and ophthalmological endpoints gathered from standardised seven field colour fundus photography, spectral domain optical coherence tomography, microperimetry and a hand-held portable electroretinography device (RETeval), were obtained and used in the work presented here as potential screening predictors for presence of MCI. MCI and normocognition (NC) were determined based on a full neuropsychological test battery and the Clinical Dementia Rating score. A stepwise selection of variables, based on Akaike's information criterion, and logistic regression models for predicting MCI were undertaken. Area under the receiver-operating characteristic curve analyses were used to predict the probability of the presence of MCI as well as sensitivity and specificity cut-off points. RESULTS: A total of 313 people living with diabetes (128 with NC and 185 with MCI) were included. People with diabetes with MCI were older (p=0.006) and had fewer years of education (p<0.001), lower retinal sensitivity (p=0.01) and less capacity of gaze fixation (p≤0.001) than those with NC. Statistically significant differences in pupillary area ratio (p=0.002) and photopic b-wave amplitude (p=0.03) were detected between people with diabetes with NC and with MCI. Multivariable logistic regression showed that the best model to identify people with diabetes with MCI was that combining retinal sensitivity, gaze fixation, photopic b-wave amplitude and pupillary size change following stimulation, years of education, DSDRS and MoCA score, with an AUC of 0.84 (sensitivity 79.9, specificity 79.0). The visuo-construction domain was the most affected in people with diabetes with MCI and its impairment was independently related to retinal sensitivity and gaze fixation. CONCLUSIONS/INTERPRETATION: The assessment of retinal neurodysfunction in combination with simple clinical variables appears useful to identify people with diabetes with MCI. This strategy could optimise current screening of MCI in people living with diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Simó R, Hernández C, Frontoni S, et al. Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study. Diabetologia. 2026. PMID: 41611978. doi:10.1007/s00125-025-06664-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。